Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bionik Laboratories Corp (OP:BNKL)

0.0001 UNCHANGED
Last Price Updated: 11:30 AM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0001
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0001
Today's Range 0.0001 - 0.0001
52wk Range 0.0001 - 0.0001
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bionik Laboratories Reports a Significant Increase in Patient Volume at Its Acquired Rehabilitation Center in Florida
From Bionik Laboratories Corp.
Via Business Wire
Bionik Laboratories Enters into Distribution Agreement with Pro-Med Technology for the Sale of InMotion® Robotic Devices in Hong Kong
From Bionik Laboratories Corp.
Via Business Wire

Performance

More News

Read More
Bionik Laboratories’ InMotion® Robotic Devices on Display at the Korea International Medical & Hospital Equipment Show (KIMES)
From Bionik Laboratories Corp.
Via Business Wire
BIONIK Laboratories to Present at National Investment Banking Association Conference
Via ACCESSWIRE
Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results
From Bionik Laboratories Corp.
Via Business Wire
Bionik Laboratories Reports Second Quarter Fiscal Year 2023 Financial Results
From Bionik Laboratories Corp.
Via Business Wire
Bionik Laboratories to Present at the Q4 Virtual Investor Summit
Via NewMediaWire
Bionik Laboratories Appoints Richard Russo, Jr. as Chief Executive Officer and Dan Gonsalves as Chief Financial Officer
From Bionik Laboratories Corp.
Via Business Wire
Bionik Laboratories Acquires Florida Rehabilitation Center; First in Strategic National Rollout
From Bionik Laboratories Corp.
Via Business Wire
BIONIK Laboratories Reports First Quarter Financial Results
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories Corp. to Present at Investor Summit Group’s Q3 Virtual Conference
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories Announces the Sale & Installation of a New InMotion® ARM/HAND Robotic Device to Tampa General Hospital for its Rehabilitation Center
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories Reports Fourth Quarter and Fiscal Year 2022 Financial Results
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories: Strong Sales Pipeline Delivering Hope to Stroke Survivors
Via NewMediaWire
BIONIK Laboratories to Attend the 2022 American Occupational Therapy Association (AOTA) Conference & Expo
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories Reports 15-20% Increase in Therapeutic Gains on InMotion® Robotic Devices in New Patient Outcomes Data Report
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories Reports Third Quarter Fiscal Year 2022 Financial Results
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories to Participate at the American Physical Therapy Association Conference
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories to Participate at MEDICA, a Leading International Trade Show for the Medical Industry
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories Reports Second Quarter Fiscal Year 2022 Financial Results
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories Announces Commercial Team Addition With Newly Hired Regional Sales Director, Tony Bellofatto
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories Reports a 72% Increase in Patient Sessions on its InMotion® Robotic Devices Since Launch of InMotion Connect™ Platform
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories Reports Fiscal 2022 Q1 Financial Results
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories Announces $5 Million Capital Raise through Issuance of Convertible Notes
From BIONIK Laboratories Corp.
Via Business Wire
BIONIK Laboratories Announces Resignation of CEO, Names Interim CEO
From BIONIK Laboratories Corp.
Via Business Wire

Frequently Asked Questions

Is Bionik Laboratories Corp publicly traded?
Yes, Bionik Laboratories Corp is publicly traded.
What exchange does Bionik Laboratories Corp trade on?
Bionik Laboratories Corp trades on the OTC Traded
What is the ticker symbol for Bionik Laboratories Corp?
The ticker symbol for Bionik Laboratories Corp is BNKL on the OTC Traded
What is the current price of Bionik Laboratories Corp?
The current price of Bionik Laboratories Corp is 0.0001
When was Bionik Laboratories Corp last traded?
The last trade of Bionik Laboratories Corp was at 10/21/25 11:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.